Fuchs Henry J
SEC-identified person · CIK 1197355 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Biomarin Pharmaceutical INC BMRN | President, Worldwide R&D | filed 2009 - 2024 |
| Mirati Therapeutics, Inc. mrtx | Director | filed 2013 - 2023 |
| Genomic Health INC GHDX | Director | filed 2013 - 2019 |
| Intrabiotics Pharmaceuticals INC /DE RDEA | Director | filed 2006 - 2012 |
| Onyx Pharmaceuticals INC ONXX | EVP & Chief Medical Officer | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.